Colorectal cancer (CRC) is the third cancer among the known causes of cancer that impact
people. Although CRC drug options are imperfect, primary detection of CRC can play a key …

Introduction Recent statistics have reported colorectal cancer (CRC) as the second leading
cause of cancer-associated deaths in the world. Early diagnosis of CRC may help to reduce …

Glycosylated pH-sensitive mesoporous silica nanoparticles (MSNs) of capecitabine (CAP)
were developed for targeting colorectal cancer. The MSNs possessed an average pore …

Microbial biofilms, structured communities of microorganisms, have been often associated to
the infection and bacterial multiresistance problem. Conventional treatment of infection …

Herein, we have developed folic acid conjugated capecitabine capped passivated carbon
dots (CAP-FA-CDPs) for colorectal cancer targeting. Carbon dots were synthesized via a …

Polymeric nanoparticles are widely studied in the treatment of colorectal cancer.
Kaempferitrin‐loaded nontoxic and biodegradable poly (d, l‐lactic‐co‐glycolic acid)(PLGA) …

The key objective of the current research was to fabricate and optimize Capecitabine (Cap)-
loaded [poly (lactic-co-glycolic acid)] PLGA-based nanoparticles (NPs) by enabling quality …

In recent years, nano and micro drug delivery systems targeting the colon have gained more
attention due to increasing interest in treating colon diseases such as colorectal cancer and …

Abstract Oral prodrug of 5-fluorouracil (5-FU), capecitabine, has revolutionized the treatment
of colon cancer, providing high efficacy and convenient administration. This review …

Benznidazole is a promising antitumor drug because it has the ability to induce the
production of intracellular reactive oxygen species. In this study, poly (d, l-lactide-co …